Mutation in IL 36 RN impairs the processing and regulatory function of the interleukin‐36‐receptor antagonist and is associated with DITRA syndrome-Reference-Cited by-同舟云学术

Mutation in IL 36 RN impairs the processing and regulatory function of the interleukin‐36‐receptor antagonist and is associated with DITRA syndrome

Published:2017-10-26 Issue:10 Volume:28 Page:1114-1117
ISSN:0906-6705
Container-title:Experimental Dermatology
language:en
Short-container-title:Exp Dermatol

Author:

Bal Elodie¹,Lim Ai Ching²,Shen Min²,Douangpanya Jason²,Madrange Marine¹,Gazah Rihab¹,Tauber Marie¹,Beghdadi Walid³,Casanova Jean Laurent⁴⁵⁶,Bourrat Emmanuelle⁷⁸,Bachelez Hervé¹⁷⁹,Towne Jennifer E.²¹⁰,Smahi Asma¹^ORCID

Affiliation:

1. Sorbonne Paris CitéIMAGINE InstituteNecker Hospital, Enfants‐MaladesUMR 1163, Paris‐Descartes University Paris France

2. Inflammation Research and Therapeutic DiscoveryAmgen Inc. Seattle WA USA

3. Clinical Research UnitAPHP Saint‐Louis Hospital Paris France

4. Rockefeller BranchSt. Giles Laboratory of Human Genetics of Infectious DiseasesThe Rockefeller University New York NY USA

5. Necker BranchLaboratory of Human Genetics of Infectious DiseasesSorbonne Paris CitéIMAGINE InstituteNecker Hospital, Enfants‐MaladesUMR 1163, Paris‐Descartes University Paris France

6. Pediatric Hematology‐Immunology‐Rheumatology UnitAP‐HP, Necker Enfants Malades Hospital Paris France

7. Sorbonne Paris CitéParis Diderot University Paris France

8. Department of PediatricsAPHP Robert Debré Hospital Paris France

9. Department of DermatologyAPHP, Saint‐Louis Hospital Paris France

10. Moved to Janssen Research & Development LLC San Diego CA USA

Funder

Amgen

Pfizer

Publisher

Wiley

Subject

Dermatology,Molecular Biology,Biochemistry